Hypopituitarism Clinical Trial
Official title:
The Global Hypopituitary Control and Complications Study
The Hypopituitary Control and Complications Study "HypoCCS" is a prospective, open label,
global, multicentre, observational study on routine clinical care of adults with growth
hormone deficiency occurring either isolated or in combination with other pituitary hormone
deficiencies. The objective of this observational study is to evaluate long-term safety and
health outcomes for adult growth hormone deficient participants with or without somatropin
replacement therapy. As an observational study, data are collected only as provided at the
discretion of the attending physician. The participant enrolled meet the criteria of growth
hormone deficiency in adults as per the Humatrope label in the country where their attending
physician practices, and this diagnosis is at the discretion of the attending physician. The
decision to receive somatropin or remain untreated is made by the participant in
consultation with their attending physician.
While treatment of adult growth hormone deficient participants with somatropin has been
shown to be safe and effective in clinical trials of 18 months duration, this observational
study aims to provide information on health outcome and replacement therapy over longer
periods of time for a larger number of participants in the context of the overall disease
environment.
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT02871986 -
Pubertal Induction in Individuals With Hypogonadism
|
N/A | |
| Completed |
NCT00851942 -
Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test
|
Phase 4 | |
| Completed |
NCT00507104 -
Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
|
||
| Completed |
NCT00027430 -
Androgen Replacement Therapy in Women With Hypopituitarism
|
N/A | |
| Recruiting |
NCT04897802 -
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
|
Phase 4 | |
| Not yet recruiting |
NCT06014398 -
Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours
|
N/A | |
| Recruiting |
NCT04121780 -
Growth Hormone Replacement Therapy for Retried Professional Football Players
|
Phase 2 | |
| Not yet recruiting |
NCT01666964 -
Hormone Deficiency After Brain Injury During Combat
|
N/A | |
| Completed |
NCT01028742 -
Posttraumatic Hypopituitarism - Incidence, Predictors and Test Validity
|
N/A | |
| Completed |
NCT00139945 -
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
|
N/A | |
| Completed |
NCT05206149 -
Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes
|
Phase 4 | |
| Completed |
NCT05188131 -
Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium
|
Phase 4 | |
| Completed |
NCT00133354 -
Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT03708523 -
Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy
|
||
| Completed |
NCT01007071 -
Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency
|
Phase 3 | |
| Not yet recruiting |
NCT06326853 -
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
|
||
| Completed |
NCT00080483 -
Testosterone and Growth Hormone for Bone Loss in Men
|
Phase 2 | |
| Completed |
NCT01009905 -
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
|
N/A | |
| Completed |
NCT01209416 -
The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
|
N/A | |
| Completed |
NCT04902235 -
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
|
Phase 4 |